New Delhi, March 31: India's bioeconomy is approaching the $200 billion mark, which is a significant milestone in its development, according to a report released on Tuesday. This is due to strong policy support and a growing pipeline of innovation.The report by Endiya Partners said that the...
Lupin Receives Tentative USFDA Approval for Generic Pitolisant Tablets
New Delhi, March 25 – Lupin Ltd announced on Wednesday that it has received tentative approval from the US health regulator for its generic version of Pitolisant tablets, indicated for the treatment of excessive daytime...
abbreviated new drug application
drugdevelopmentdrug manufacturing
excessive daytime sleepiness
generic pharmaceuticals
healthcare
india
lupin ltd
nagpur
pharmaceutical approval
pharmaceutical industry
pitolisant
regulatory filings
tablet
us food and drug administration (usfda)
Novo Nordisk Drops Lawsuit Against Hims & Hers After Agreement to Sell Wegovy and Ozempic Through Platform
Novo Nordisk has dropped its lawsuit against telehealth company Hims & Hers after both firms reached an agreement that will allow the pharmaceutical company’s branded weight loss...
India Targets 5 to 6 Percent Global Chemical Share by 2030, Eyes $1 Trillion Turnover by 2040
Government Bets on Bio-Pharma SHAKTI and Chemical Parks to Boost Sector Growth
New Delhi, March 4: India is positioning itself for a major leap in the global chemical and biopharmaceutical landscape...
bio-pharma
biologics
biosimilars
cdsco
chemical parks
chemical sector
circular economy
drugdevelopment
fermentation
india
infrastructure
niper
patent expiration
research and development
turnover